Acute hepatitis C treatment
Journal Title: Annals of Hepatology - Year 2010, Vol 9, Issue 0
Abstract
There are no well established treatment guidelines about acute hepatitis C (AHC), leaving physicians to make several challenging decisions, such whether to treat, when to treat and what treatment regimens to use. This article examines the diagnosis of acute infection and critically appraises the various treatment regimens.
Authors and Affiliations
Paulo Lerias de Almeida
The use of sildenafil to treat portopulmonary hypertension prior to liver transplantation
Portopulmonary hypertension (PPH) is an infrequent, but well-recognized complication of liver cirrhosis. PPH in those with end-stage liver disease has a significant impact on per-operative and intra-operative mortality,...
Contribution on the topic of hypovitaminosis D in chronic hepatitis C
Polycystic liver disease: a clinical review
Polycystic liver disease rarely occurs in isolation as part of autosomal dominant polycystic liver disease, but more commonly, it exists as an extra-renal manifestation of autosomal dominant polycystic kidney disease. T...
Is intestinal oxidative stress involved in patients with compensated liver cirrhosis?
Background. Liver cirrhosis is associated with intestinal epithelial barrier dysfunction, which may be affected by oxidative stress.Studies in cirrhotic rats provided evidence for intestinal oxidative stress, but studie...
Acute Liver Failure Due to Etodolac, a Selective Cycloxygenase- 2 (COX -2) Inhibitor Non-Steroidal Anti-Inflammatory Drug Established by RUCAM-Based Causality Assessment
Drug induced liver injury is a common cause of acute liver failure (ALF). While most of these cases are due to dose dependent hepatotoxicity with acetaminophen, idiosyncratic drug-induced liver injury (DILI) is responsib...